September 14, 2021
ASCOT removes aspirin from trial
ASCOT is an adaptive platform trial allowing for addition or removal of treatment arms based on interim findings and external evidence
September 14, 2021
ASCOT is an adaptive platform trial allowing for addition or removal of treatment arms based on interim findings and external evidence
September 9, 2021
Professor Allen Cheng is hopeful about the future, as the “headwinds” of the Delta variant will be reversed by the “tailwinds” of vaccination
September 7, 2021
The report emphasises a need for greater coordination and efficiency to address the current and future infectious diseases emergencies
August 31, 2021
Children can get long COVID, but it seems to be less common than in adults and they tend to recover quicker
August 19, 2021
Maintaining and promoting trust is important when it comes to vaccine mandates
August 10, 2021
APPRISED – the newsletter of the APPRISE Centre of Research Excellence contains news about our response to infectious disease emergencies
August 2, 2021
The main advantages of antigen tests for SARS-CoV-2 (the COVID-19 virus) over PCR tests include their lower cost and their speed
July 21, 2021
Clinical trials are the best way to offer patients new therapies and to generate the evidence about which therapies work
July 19, 2021
The ISARIC clinical data platform is the largest international individual patient dataset of COVID-19 hospitalised cases
July 14, 2021
CRISPR gene editing tool suppresses replication of SARS-CoV-2 variants in a test tube model